These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 26597820)

  • 1. Orphan Nuclear Receptor Nur77 Inhibits Angiotensin II-Induced Vascular Remodeling via Downregulation of β-Catenin.
    Cui M; Cai Z; Chu S; Sun Z; Wang X; Hu L; Yi J; Shen L; He B
    Hypertension; 2016 Jan; 67(1):153-62. PubMed ID: 26597820
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The orphan nuclear receptor Nur77 inhibits low shear stress-induced carotid artery remodeling in mice.
    Yu Y; Cai Z; Cui M; Nie P; Sun Z; Sun S; Chu S; Wang X; Hu L; Yi J; Shen L; He B
    Int J Mol Med; 2015 Dec; 36(6):1547-55. PubMed ID: 26498924
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nur77 downregulation triggers pulmonary artery smooth muscle cell proliferation and migration in mice with hypoxic pulmonary hypertension via the Axin2-β-catenin signaling pathway.
    Nie X; Tan J; Dai Y; Mao W; Chen Y; Qin G; Li G; Shen C; Zhao J; Chen J
    Vascul Pharmacol; 2016 Dec; 87():230-241. PubMed ID: 27871853
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NLRP3 Gene Deletion Attenuates Angiotensin II-Induced Phenotypic Transformation of Vascular Smooth Muscle Cells and Vascular Remodeling.
    Ren XS; Tong Y; Ling L; Chen D; Sun HJ; Zhou H; Qi XH; Chen Q; Li YH; Kang YM; Zhu GQ
    Cell Physiol Biochem; 2017; 44(6):2269-2280. PubMed ID: 29262411
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Upregulation of TRPM7 channels by angiotensin II triggers phenotypic switching of vascular smooth muscle cells of ascending aorta.
    Zhang Z; Wang M; Fan XH; Chen JH; Guan YY; Tang YB
    Circ Res; 2012 Oct; 111(9):1137-46. PubMed ID: 22896586
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Calcium/calmodulin-dependent kinase II inhibition in smooth muscle reduces angiotensin II-induced hypertension by controlling aortic remodeling and baroreceptor function.
    Prasad AM; Morgan DA; Nuno DW; Ketsawatsomkron P; Bair TB; Venema AN; Dibbern ME; Kutschke WJ; Weiss RM; Lamping KG; Chapleau MW; Sigmund CD; Rahmouni K; Grumbach IM
    J Am Heart Assoc; 2015 Jun; 4(6):e001949. PubMed ID: 26077587
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Notch activation mediates angiotensin II-induced vascular remodeling by promoting the proliferation and migration of vascular smooth muscle cells.
    Ozasa Y; Akazawa H; Qin Y; Tateno K; Ito K; Kudo-Sakamoto Y; Yano M; Yabumoto C; Naito AT; Oka T; Lee JK; Minamino T; Nagai T; Kobayashi Y; Komuro I
    Hypertens Res; 2013 Oct; 36(10):859-65. PubMed ID: 23719127
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Smooth muscle cell-specific Hif-1α deficiency suppresses angiotensin II-induced vascular remodelling in mice.
    Imanishi M; Tomita S; Ishizawa K; Kihira Y; Ueno M; Izawa-Ishizawa Y; Ikeda Y; Yamano N; Tsuchiya K; Tamaki T
    Cardiovasc Res; 2014 Jun; 102(3):460-8. PubMed ID: 24623277
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Angiotensin II enhances interleukin-18 mediated inflammatory gene expression in vascular smooth muscle cells: a novel cross-talk in the pathogenesis of atherosclerosis.
    Sahar S; Dwarakanath RS; Reddy MA; Lanting L; Todorov I; Natarajan R
    Circ Res; 2005 May; 96(10):1064-71. PubMed ID: 15860756
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of M3AChR (Type 3 Muscarinic Acetylcholine Receptor) and Nrf2 (Nuclear Factor Erythroid 2-Related Factor 2) Signaling by Choline Alleviates Vascular Smooth Muscle Cell Phenotypic Switching and Vascular Remodeling.
    He X; Deng J; Yu XJ; Yang S; Yang Y; Zang WJ
    Arterioscler Thromb Vasc Biol; 2020 Nov; 40(11):2649-2664. PubMed ID: 32938216
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TRPV5 attenuates abdominal aortic aneurysm in mice by regulating KLF4-dependent phenotype switch of aortic vascular smooth muscle cells.
    Wang S; Tian X; Liu D; Zhang X; Yan C; Han Y
    Arch Biochem Biophys; 2021 Feb; 698():108724. PubMed ID: 33309615
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rapamycin Treatment Attenuates Angiotensin II -induced Abdominal Aortic Aneurysm Formation via VSMC Phenotypic Modulation and Down-regulation of ERK1/2 Activity.
    Li FF; Shang XK; Du XL; Chen S
    Curr Med Sci; 2018 Feb; 38(1):93-100. PubMed ID: 30074157
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Angiotensin-converting enzyme 2 is a critical determinant of angiotensin II-induced loss of vascular smooth muscle cells and adverse vascular remodeling.
    Patel VB; Zhong JC; Fan D; Basu R; Morton JS; Parajuli N; McMurtry MS; Davidge ST; Kassiri Z; Oudit GY
    Hypertension; 2014 Jul; 64(1):157-64. PubMed ID: 24799609
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diallyl Trisulfide Suppresses Angiotensin II-Induced Vascular Remodeling Via Inhibition of Mitochondrial Fission.
    Lu ZY; Qi J; Yang B; Cao HL; Wang RY; Wang X; Chi RF; Guo CL; Yang ZM; Liu HM; Li B
    Cardiovasc Drugs Ther; 2020 Oct; 34(5):605-618. PubMed ID: 32564303
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Angiotensin II type 1 receptor-associated protein prevents vascular smooth muscle cell senescence via inactivation of calcineurin/nuclear factor of activated T cells pathway.
    Min LJ; Mogi M; Tamura K; Iwanami J; Sakata A; Fujita T; Tsukuda K; Jing F; Iwai M; Horiuchi M
    J Mol Cell Cardiol; 2009 Dec; 47(6):798-809. PubMed ID: 19769983
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epidermal growth factor receptor is critical for angiotensin II-mediated hypertrophy in cerebral arterioles.
    Chan SL; Umesalma S; Baumbach GL
    Hypertension; 2015 Apr; 65(4):806-12. PubMed ID: 25733240
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phosphorylation of smooth muscle 22α facilitates angiotensin II-induced ROS production via activation of the PKCδ-P47phox axis through release of PKCδ and actin dynamics and is associated with hypertrophy and hyperplasia of vascular smooth muscle cells in vitro and in vivo.
    Lv P; Miao SB; Shu YN; Dong LH; Liu G; Xie XL; Gao M; Wang YC; Yin YJ; Wang XJ; Han M
    Circ Res; 2012 Aug; 111(6):697-707. PubMed ID: 22798525
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Divergent roles of matrix metalloproteinase 2 in pathogenesis of thoracic aortic aneurysm.
    Shen M; Lee J; Basu R; Sakamuri SS; Wang X; Fan D; Kassiri Z
    Arterioscler Thromb Vasc Biol; 2015 Apr; 35(4):888-98. PubMed ID: 25657308
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacological inhibition and genetic deficiency of plasminogen activator inhibitor-1 attenuates angiotensin II/salt-induced aortic remodeling.
    Weisberg AD; Albornoz F; Griffin JP; Crandall DL; Elokdah H; Fogo AB; Vaughan DE; Brown NJ
    Arterioscler Thromb Vasc Biol; 2005 Feb; 25(2):365-71. PubMed ID: 15576638
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protective role of vascular smooth muscle cell PPARγ in angiotensin II-induced vascular disease.
    Marchesi C; Rehman A; Rautureau Y; Kasal DA; Briet M; Leibowitz A; Simeone SM; Ebrahimian T; Neves MF; Offermanns S; Gonzalez FJ; Paradis P; Schiffrin EL
    Cardiovasc Res; 2013 Mar; 97(3):562-70. PubMed ID: 23250918
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.